TTENK/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

TTENK/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Groups
  • Trending
  • News

More

  • Pricing
  • Community
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice.TENK is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities TENK rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. TENK/calls is an independent service and is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

TTENK/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Pulling SEC filings + quote and writing the call…

TTENK/calls
The BriefMarketsAll StocksNewsScreenerCommunity
← New search

NVZMY

Novozymes AS

PINKCommon Stock
$65.13
+4.48%today

No SEC filings for this security

Novozymes AS is a foreign or OTC-listed security (PINK) that doesn't file with the SEC, so the grounded research view — financials, filings, insider activity and the call — isn't available. Price and news only.

Key stats

52-week range$52.18 – $70.88
52.1852-week70.88
Market cap
$30.4B
Volume
5.88K
1Y return
-8.36%
Beta
0.62

Price · 1Y

$65.13▼ -8.36%
over 1Y
L $52.18H $71.07

Recent news

market news →
FUL or NVZMY: Which Is the Better Value Stock Right Now?Bullish
finance.yahoo.com· 2026-06-19
A Look At Novozymes (CPSE:NSIS B) Valuation After Recent Share Price WeaknessBullish
finance.yahoo.com· 2026-05-14
Corbion General Shareholders Meeting approves Supervisory Board appointments and dividendBullish
finance.yahoo.com· 2026-05-13
Novonesis delivered strong start to the year with 7% organic sales growth in Q1Bullish
finance.yahoo.com· 2026-05-05
Interim report Q1 2026Bullish
finance.yahoo.com· 2026-05-05
FUL vs. NVZMY: Which Stock Should Value Investors Buy Now?Bullish
finance.yahoo.com· 2026-04-16
Novozymes Dividend Increase And Valuation Discount Catch Investor AttentionBullish
finance.yahoo.com· 2026-04-04
FUL or NVZMY: Which Is the Better Value Stock Right Now?Bullish
finance.yahoo.com· 2026-03-31

Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.